We have hypothesised that DNMTi can also act through the activation of the IFNγ-signalling pathway components and we therefore focused on the expression levels of the selected genes from this pathway, namely interferon responsible factors 1 (IRF-1) and 8 (IRF-8) and STAT-1 in tumour cells. The gene discussed is IFNG; the disease is neoplasm.